This content may collect you by Sofia Jackson
We will quote to you most important and trendy news about HIV of the best health sites Like : “labiotech” and the most famous medical experts :
daily : 2017-01-03 & on time : 11:17
as mentioned in
Fresh Cash for a Device that can treat Diabetes and Prevent HIV
image uploaded by “labiotech” site
Intarcia will develop a drug delivery device for HIV prevention that can significantly reduce dosing frequency, backed by a €134M ($140M) deal with the Bill & Melinda Gates Foundation.Intarcia is a biotech unicorn from the US with an innovative drug delivery system that has managed to attract €197M ($206M) in Series EE, including €48M ($50M) from the Bill & Melinda Gates Foundation, which is offering an additional €86M ($90M) in milestones for the development a prophylactic HIV therapy.Intarcia’s Medici here
NIH Testing Injectable Cabotegravir To Prevent HIV
image uploaded by “techtimes” site
AdvertisementIn an effort to find other options as HIV pre-exposure prophylaxis (PrEP), the National Institutes of Health launched a clinical trial to test the long-acting form of cabotegravir, an experimental anti-HIV drug.Currently, the only approved PrEP regimen is Truvada, which consists of two anti-HIV drugs tenofovir disoproxil fumarate and emtricitabine.As Truvada is taken orally daily as a tablet, it may present a challenge to at-risk individuals looking for more discreet ways to prevent HIV, which the injectable cabotegravir is hoping to address.
about the details read more from here
Shots To Prevent HIV Enter Global Clinical Trials
image uploaded by “itechpost” site
HIV Prevention: Shots To Prevent HIV Enter Global Clinical TrialsThe little blue pill, Truvada, might be replaced by a simpler, more efficient method very soon.The National Institutes of Health (NIH) is taking big steps for HIV prevention with the global clinical trial of an injectable HIV-prevention drug — cabotegravir.The trials will take place in eight countries from America, Asia and Africa.